Unknown

Dataset Information

Short-term correction of arginase deficiency in a neonatal murine model with a helper-dependent adenoviral vector.


ABSTRACT: Neonatal gene therapy has the potential to ameliorate abnormalities before disease onset. Our gene knockout of arginase I (AI) deficiency is characterized by increasing hyperammonemia, neurological deterioration, and early death. We constructed a helper-dependent adenoviral vector (HDV) carrying AI and examined for correction of this defect. Neonates were administered 5 x 10(9) viral particles/g and analyzed for survival, arginase activity, and ammonia and amino acids levels. The life expectancy of arg(-/-) mice increased to 27 days while controls died at 14 days with hyperammonemia and in extremis. Death correlated with a decrease in viral DNA/RNA per cell as liver mass increased. Arginase assays demonstrated that vector-injected hepatocytes had ~20% activity of heterozygotes at 2 weeks o

SUBMITTER: Gau CL 

PROVIDER: S-EPMC2835205 | biostudies-literature | 2009 Jul

REPOSITORIES: biostudies-literature